Elucid vs Ultromics EchoGo
Elucid's PlaqueIQ has Category I CPT 75577 from January 1, 2026. A dicardiology.com report puts Medicare's national average payment to the performing site at about $1,012 in imaging centers and physician offices and $951 under OPPS, the hospital outpatient payment system (currency not stated for both). Those figures are what Medicare pays the site, and Elucid lists no public price, billing providers per analysis. Ultromics lists CPT Category III 0932T for EchoGo Heart Failure, and a CMS update dated December 12, 2024 assigns APC 5743.
A cardiology group with coronary CT angiography volume fits Elucid. Per the company's 2024 release, the physician sends the images, trained analysts segment a 3D model of the coronary arteries, and the software quantifies plaque. openFDA gives decisions on September 12, 2024 under K241524 and September 18, 2026 under K261855.
An echo reading service fits Ultromics. With coronary CT angiography as the volume, Elucid is the buy and Ultromics sits second, since EchoGo's modality is transthoracic echocardiography.
Radiology · Reviewed November 2, 2026
Elucid
by Elucid Bioimaging
PlaqueIQ analyzes coronary plaque on CT angiograms, with FDA 510(k) clearances in September 2024 and September 2026.
Ultromics EchoGo
by Ultromics
FDA-cleared AI on echocardiograms that flags heart failure with preserved ejection fraction and screens for cardiac amyloidosis.
When to pick each one
Elucid
- Category I CPT code 75577 from January 1, 2026
- PlaqueIQ decisions September 2024 and September 2026
- Billed per analysis on coronary CT angiograms
Ultromics EchoGo
- CPT Category III 0932T with APC 5743
- Reads transthoracic echo studies
Score
Each row shows points earned of points available under the published rubric.
Elucid
43of 100
Ultromics EchoGo
42of 100
| Dimension | Elucid | Ultromics EchoGo | Difference |
|---|---|---|---|
| FDA clearance | 18 / 18 | 18 / 18 | 0 |
| HIPAA / SOC2 / BAA | 0 / 10 | 6 / 10 | -6 |
| EHR integrations (count) | 0 / 4.2 | 0 / 4.2 | 0 |
| Top-3 EHR coverage (Epic / Oracle / Athena) | 0 / 2.4 | 0 / 2.4 | 0 |
| Peer-reviewed papers | 12.7 / 18.2 | 0 / 18.2 | +12.7 |
| RCT / meta-analysis / systematic review | 0 / 7.8 | 0 / 7.8 | 0 |
| Funding & adoption signal | 3 / 12 | 8.4 / 12 | -5.4 |
| Pricing transparency | 2.5 / 5 | 2.5 / 5 | 0 |
| Years in market | 0 / 6 | 0 / 6 | 0 |
Scroll horizontally to see every column.
Pricing
Elucid
| Tier | Monthly | Annual | Notes |
|---|---|---|---|
| Per analysis | n/a | n/a | No public price. Providers are billed per analysis. Category I CPT code 75577 has applied since January 1, 2026. |
Ultromics EchoGo
| Tier | Monthly | Annual | Notes |
|---|---|---|---|
| Enterprise | n/a | n/a | No public price. |
Evidence
Elucid
FDA decisions
K261855 (opens in new tab)510(k)2026-09-18
Elucid PlaqueIQ
K241524 (opens in new tab)510(k)2024-09-12
Elucid PlaqueIQ
Peer-reviewed
2 PubMed records name Elucid.
Ultromics EchoGo
FDA decisions
K240860 (opens in new tab)510(k)2024-11-15
EchoGo Amyloidosis (1.0)
K240013 (opens in new tab)510(k)2024-09-23
EchoGo Heart Failure (2.0)
K222463 (opens in new tab)510(k)2022-11-23
EchoGo Heart Failure 1.0
K213275 (opens in new tab)510(k)2021-12-20
EchoGo Core (2.0)
K201555 (opens in new tab)510(k)2020-12-18
EchoGo Pro v1.0.2
Show 1 more
K191171 (opens in new tab)510(k)2019-11-13
EchoGo Core
Compliance and integrations
Documented from each vendor’s own pages.
| Spec | Elucid | Ultromics EchoGo |
|---|---|---|
| Free tier | ||
| HIPAA | ||
| SOC 2 Type II | ||
| EHR integrations | Not specified | Not specified |
| Founded | n/a | n/a |
| HQ | n/a | GB |
Scroll horizontally to see both columns.
Common questions
Open the full radiology comparison
Acute-care triage, mammography screening, CCTA plaque analysis, mobile MRI. 30+ FDA-cleared platforms across stroke, oncology, cardiac. Enterprise sales only — we compared what's deployed where.